Total Payments
$7,547
2024 Payments
$277.37
Companies
10
Transactions
30
Medicare Patients
2,254
Medicare Billing
$511,292
Payment Breakdown by Category
Research$7,113 (94.2%)
Food & Beverage$434.26 (5.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $7,113 | 4 | 94.2% |
| Food and Beverage | $434.26 | 26 | 5.8% |
Payments by Type
Research
$7,113
4 transactions
General
$434.26
26 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eli Lilly and Company | $7,113 | 4 | $0 (2021) |
| Medline Industries LP | $159.69 | 14 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $65.16 | 4 | $0 (2024) |
| Boston Scientific Corporation | $45.66 | 1 | $0 (2018) |
| Inspire Medical Systems, Inc. | $45.00 | 1 | $0 (2024) |
| Organogenesis Inc. | $29.95 | 1 | $0 (2024) |
| Genentech USA, Inc. | $28.91 | 2 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $20.26 | 1 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $20.07 | 1 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $19.56 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $277.37 | 18 | Medline Industries LP ($159.69) |
| 2022 | $20.26 | 1 | Sunovion Pharmaceuticals Inc. ($20.26) |
| 2021 | $2,789 | 5 | Eli Lilly and Company ($2,733) |
| 2020 | $3,645 | 3 | Eli Lilly and Company ($3,630) |
| 2019 | $749.93 | 1 | Eli Lilly and Company ($749.93) |
| 2018 | $45.66 | 1 | Boston Scientific Corporation ($45.66) |
| 2017 | $19.56 | 1 | Valeant Pharmaceuticals North America LLC ($19.56) |
All Payment Transactions
30 individual payment records from CMS Open Payments — Page 2 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/26/2020 | Eli Lilly and Company | — | — | In-kind items and services | $706.97 | Research |
| Study: THE EFFECT OF TIRZEPATIDE VERSUS DULAGLUTIDE ON MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE 2 DIABETES (SURPASS CVOT) | ||||||
| 01/28/2020 | Eli Lilly and Company | — | — | In-kind items and services | $2,922.68 | Research |
| Study: PHASE 1, MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, TRIPLE-BLIND, SINGLE-ASCENDING DOSE AND REPEAT-DOSE TRIAL IN HEALTHY PARTICIPANTS AND PARTICIPANTS WITH ATOPIC DERMATITIS | ||||||
| 07/25/2019 | Eli Lilly and Company | — | — | In-kind items and services | $749.93 | Research |
| Study: PHASE 1, MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, TRIPLE-BLIND, SINGLE-ASCENDING DOSE AND REPEAT-DOSE TRIAL IN HEALTHY PARTICIPANTS AND PARTICIPANTS WITH ATOPIC DERMATITIS | ||||||
| 05/21/2018 | Boston Scientific Corporation | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $45.66 | General |
| Category: STRUCTURAL HEART | ||||||
| 06/29/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: GASTROENTEROLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PHASE 1, MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, TRIPLE-BLIND, SINGLE-ASCENDING DOSE AND REPEAT-DOSE TRIAL IN HEALTHY PARTICIPANTS AND PARTICIPANTS WITH ATOPIC DERMATITIS | Eli Lilly and Company | $6,406 | 3 |
| THE EFFECT OF TIRZEPATIDE VERSUS DULAGLUTIDE ON MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE 2 DIABETES (SURPASS CVOT) | Eli Lilly and Company | $706.97 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 426 | 1,641 | $238,105 | $118,711 |
| 2022 | 4 | 397 | 1,178 | $175,680 | $82,184 |
| 2021 | 5 | 548 | 1,476 | $225,640 | $103,266 |
| 2020 | 9 | 883 | 3,522 | $413,485 | $207,131 |
Total Patients
2,254
Total Services
7,817
Medicare Billing
$511,292
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 124 | 1,182 | $153,660 | $79,495 | 51.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 135 | 164 | $41,000 | $18,050 | 44.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 118 | 140 | $23,800 | $9,601 | 40.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 132 | $14,520 | $8,699 | 59.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 12 | 12 | $3,100 | $1,623 | 52.4% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 11 | 11 | $2,025 | $1,243 | 61.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 116 | 815 | $105,950 | $50,563 | 47.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 133 | 158 | $39,500 | $18,525 | 46.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 116 | 128 | $21,760 | $7,948 | 36.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 32 | 77 | $8,470 | $5,147 | 60.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 144 | 982 | $127,660 | $60,957 | 47.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 174 | 215 | $53,750 | $24,257 | 45.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 152 | 179 | $30,430 | $11,157 | 36.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 58 | 80 | $8,800 | $4,046 | 46.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 20 | 20 | $5,000 | $2,849 | 57.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 152 | 1,259 | $163,670 | $79,773 | 48.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 126 | 681 | $74,960 | $41,132 | 54.9% |
| 99490 | Chronic care management services at least 20 minutes per calendar month | Office | 2020 | 142 | 1,021 | $66,365 | $35,338 | 53.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 174 | 190 | $47,575 | $22,693 | 47.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 141 | 154 | $26,180 | $9,740 | 37.2% |
| 99348 | Established patient home visit, typically 25 minutes | Office | 2020 | 69 | 138 | $17,250 | $9,415 | 54.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 51 | 51 | $12,750 | $6,273 | 49.2% |
| 99343 | New patient home visit, typically 45 minutes | Office | 2020 | 14 | 14 | $2,425 | $1,559 | 64.3% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 14 | 14 | $2,310 | $1,209 | 52.3% |
About Dr. Blanca Gonzalez, M.D
Dr. Blanca Gonzalez, M.D is a Family Medicine healthcare provider based in Hialeah, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/22/2010. The National Provider Identifier (NPI) number assigned to this provider is 1598087280.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Blanca Gonzalez, M.D has received a total of $7,547 in payments from pharmaceutical and medical device companies, with $277.37 received in 2024. These payments were reported across 30 transactions from 10 companies. The most common payment nature is "" ($7,113).
As a Medicare-enrolled provider, Gonzalez has provided services to 2,254 Medicare beneficiaries, totaling 7,817 services with total Medicare billing of $511,292. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Hialeah, FL
- Active Since 02/22/2010
- Last Updated 06/17/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1598087280
Products in Payments
- XIFAXAN (Drug) $84.72
- WATCHMAN (Device) $45.66
- INSPIRE (Device) $45.00
- Xofluza (Drug) $28.91
- GEMTESA (Drug) $20.26
- XARELTO (Drug) $20.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Hialeah
Dr. Jose Orcasita-Ng, M.d, M.D
Family Medicine — Payments: $51,855
Family Medicine $51,855
Rafael Abreu, M.d, M.D
Family Medicine — Payments: $24,889
Family Medicine $24,889
Dr. Jorge Travieso, Md, MD
Family Medicine — Payments: $8,296
Family Medicine $8,296
Wayne Case, Md, MD
Family Medicine — Payments: $7,438
Family Medicine $7,438
Amit Sharma, Do, DO
Family Medicine — Payments: $7,365
Family Medicine $7,365
Dr. Pedro Alvarez, Do, DO
Family Medicine — Payments: $7,251
Family Medicine $7,251